Healthcare News

EXTON, Pa., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...

RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) and Purdue Pharma (Canada) announced today that BELBUCA® (buprenorphine) buccal...

SALT LAKE CITY, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB:NUMD), a medical device development company announced it has begun to have its securities designated and traded as OTCQB...

NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage biotechnology company developing cancer therapeutics, today announced that Mack Roach III, M.D.,...

EAST RUTHERFORD, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs),...

VANCOUVER, British Columbia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V:CBW) ("Wheaton Income" or "Wheaton" or the "Company") is pleased to...

NORWOOD, MA--(Marketwired - January 30, 2018) - Award will support ~415-patient, 6-month Phase 2b study designed to provide clear evidence of clinical benefit for people with CFEvent rate of pulmonary...

AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program for Potential Treatment of Autoimmune Diseases and Other Immune-Mediated Disorders ...

DURHAM, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced the appointment of Mark W. Hahn as the company’s Chief Financial Officer.  A veteran Chief...

CONSHOHOCKEN, Pa., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL) today announced that Week 12 Phase 2 results for MGL-3196, its first-in-class, oral, once-daily,...